For example, the inhibition of Miro1 impairs mitophagy and β-cell function in T2DM, which impairs insulin signaling by inhibiting the IRS-AKT-FOXO1 pathway, leading to a reduction in glucose tolerance in diabetes (Chen et al., 2017). This evidence concerns the gene INS and type 2 diabetes mellitus.